Beta-thalassemia patients doing well 20 years after stem cell transplant

10/22/2013 | Healio (free registration)

More than 20 years after receiving hematopoietic stem cell transplants for the treatment of beta-thalassemia, 109 patients' long-term health-related quality of life was comparable to that of the general population. Based on responses to the Medical Outcomes Study 36-Item Short-Form Health Survey and the Functional Assessment of Cancer Therapy–Bone Marrow Transplant, patients had better quality-of-life profiles after stem cell transplants than with conventional treatment. Patients who were older at transplant and those who developed graft-versus-host disease had poorer outcomes for general health.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC